Cargando…
MAP2 immunoreactivity deficit is conserved across the cerebral cortex within individuals with schizophrenia
Several postmortem studies have reported lower levels of immunoreactivity (IR) for microtubule-associated protein 2 (MAP2) in several cortical regions of individuals with schizophrenia (SZ). However, whether this effect is conserved across multiple brain areas within an individual with SZ or if it i...
Autores principales: | DeGiosio, Rebecca, Kelly, Ryan M., DeDionisio, Adam M., Newman, Jason T., Fish, Kenneth N., Sampson, Allan R., Lewis, David A., Sweet, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713711/ https://www.ncbi.nlm.nih.gov/pubmed/31462659 http://dx.doi.org/10.1038/s41537-019-0081-0 |
Ejemplares similares
-
Mapping Synaptic Pathology within Cerebral Cortical Circuits in Subjects with Schizophrenia
por: Sweet, Robert A., et al.
Publicado: (2010) -
MAP2 is differentially phosphorylated in schizophrenia, altering its function
por: Grubisha, M. J., et al.
Publicado: (2021) -
More than a marker: potential pathogenic functions of MAP2
por: DeGiosio, Rebecca A., et al.
Publicado: (2022) -
PAK1 Protein Expression in the Auditory Cortex of Schizophrenia Subjects
por: Deo, Anthony J., et al.
Publicado: (2013) -
GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia
por: Gonzalez-Burgos, Guillermo, et al.
Publicado: (2011)